transCampus Team, 
The German Research Foundation DFG announced on 10 May 2024 that the International Research Training Group “Metabolic and Endocrine Drivers of Infection Susceptibility” is among the 17 new DFG-funded research training groups. The new group called MEDIS is a joint initiative of University of Zurich, the Swiss Federal Institute of Technology Zurich (ETH Zurich) and TU Dresden, led by Prof. Stefan Bornstein, Director of the Medical Clinic and Policlinic III at the University Hospital Dresden. MEDIS will expand and strengthen the international research network on metabolic, endocrine and infectious diseases, as Stefan Bornstein is also speaker of the International Research Training Group on metabolic diseases with King’s College London, and some of the PIs are involved in both groups.
Congratulations on this great success therefore also came from King’s: “This is another great achievement that is a testimony of Stefan’s vision and skill” said Mauro Giacca, Head of the School of Cardiovascular and Metabolic Medicine & Sciences, in his congratulations.
Shitij Kapur, Vice-Chancellor and President of King’s College London, said he was looking forward to the academic fruits of this “remarkable collaboration”, which would open up new opportunities to strengthen the continental links between King’s and its partners.
This unique collaboration aims to deepen the understanding of the relationship between metabolic and infectious diseases and to foster a new generation of talented physicians and scientists, laying the foundation for the establishment of another transCampus of TUD with UZH and ETH Zurich. The DFG is funding MEDIS with approximately six million euros, and the IRTG will be established at the Faculty of Medicine of TUD.